Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

European stocks shake off fears of new wave of tariffs

Published 09/17/2018, 05:02 AM
Updated 09/17/2018, 05:02 AM
© Reuters. The German share price index DAX graph at the stock exchange in Frankfurt

By Helen Reid

LONDON (Reuters) - European shares recovered rapidly from a weak start on Monday after reports U.S. President Trump plans new 10 percent tariffs on $200 billion of Chinese imports, with investors focusing on strong results.

Despite China's Foreign Ministry also saying it would respond to Trump's threat, an early fall across European benchmarks evaporated with just Germany's DAX still in the red by 0840 GMT.

The pan-European STOXX 600 reversed early losses to rise 0.2 percent, while Germany's DAX, home to large exporters and carmakers, was down 0.2 percent. Chinese stocks had fallen to their lowest close in nearly four years overnight.

"I think the market has digested more or less all this rollercoaster with tariffs," said Dimitrios Stefanopoulos, portfolio manager at AlphaTrust in Athens, adding that investors believe Trump will seek a deal ahead of U.S. mid-term elections.

The market was buoyed by strong defensive telecoms and utilities stocks. Cyclicals sectors, which are more sensitive to trade and economic growth, have lagged as the trade war ramped up over the past months.

"If the trade war hits the economy, then defensives will be better off," said Stefanopoulos.

On Monday several stocks shone after results, helping support risk appetite.

Forecast-beating sales from H&M (ST:HMb) sent the shares up 12.6 percent, an encouraging result for the world's second-biggest fashion retailer whose shares are down 43 percent from their level a year ago.

The large amount of H&M shares being shorted by investors makes any positive news a significant boost for the stock as short sellers are "squeezed" to unravel their position.

Belgian biotech firm Argenx (BR:ARGX) jumped 13 percent after it reported positive results from a trial of its Efgartigimod drug for primary immune thrombocytopenia.

Casino (PA:CASP) shares rose 2.9 percent after the French supermarket's parent Rallye , through which Jean-Charles Naouri exercises control of the firm, got a new 500 million euro credit facility.

Rallye (PA:GENC) shares - which are highly shorted - jumped 6.9 percent.

Credit Suisse (S:CSGN) shares dipped 0.1 percent after Swiss regulator Finma said the lender had failed in its duty to combat corruption in cases linked to FIFA and Venezuelan and Brazilian state oil companies.

The stock was likely supported by an interview with CEO Tidjane Thiam in Swiss newspaper NZZ am Sonntag, in which he said Credit Suisse was aiming for an annual profit of 5 to 6 billion francs for the next two years.

And on the M&A front, reinsurer Scor (PA:SCOR) rose 1.7 percent after sources told Reuters unlisted French cooperative insurer Covea was working on a new approach for Scor after its friendly 8.2 billion euro offer was rejected last month.

While the potential tariffs on China were reported to be 10 percent, lower than the 25 percent the administration had previously said it was considering, economists said this would still have a significant impact on markets.

© Reuters. The German share price index DAX graph at the stock exchange in Frankfurt

"Our U.S. economists expect that even a 10 percent tariff rate will slow growth in Q4, resulting in the Fed skipping a December hike," wrote UBS strategists.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.